A full list of publications can be found here.

2014-2017

  1. Clonal Hematopoiesis and Atherosclerosis.  Jaiswal S, Natarajan P, Ebert BL.  N Engl J Med. 2017;377(14):1401-2. doi: 10.1056/NEJMc1710381. PubMed PMID: 28976867.
  2. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.  Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S*, Ebert BL*.  N Engl J Med. 2017;377(2):111-21. doi: 10.1056/NEJMoa1701719. PubMed PMID: 28636844.
  3. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, Bosworth A,  Francisco L, He J, Bansal A, Morgan EA, Lacasce AS, Freedman AS, Fisher DC, Jacobsen E, Armand P, Alyea EP, Koreth J, Ho V, Soiffer RJ, Antin JH, Ritz J, Nikiforow S, Forman SJ, Michor F, Neuberg D, Bhatia R, Bhatia S, Ebert BL. J Clin Oncol. 2017 May 10;35(14):1598-1605. doi: 10.1200/JCO.2016.71.6712. Epub 2017 Jan 9. PubMed PMID: 28068180; PubMed Central  PMCID: PMC5455707.
  4. Clonal hematopoiesis. Jan M, Ebert BL, Jaiswal S. Semin Hematol. 2017 Jan;54(1):43-50. doi: 10.1053/j.seminhematol.2016.10.002. Epub 2016 Oct 20. Review. PubMed PMID: 28088988.
  5. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.  Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL. Blood. 2015 Jul 2;126(1):9-16. doi: 10.1182/blood-2015-03-631747. Epub 2015 Apr 30. PubMed PMID: 25931582; PubMed Central PMCID: PMC4624443.
  6. Clonal hematopoiesis and blood-cancer risk. Genovese G, Jaiswal S, Ebert BL, McCarroll SA. N Engl J Med. 2015 Mar 12;372(11):1071-2. doi: 10.1056/NEJMc1500684. PubMed PMID: 25760361.
  7. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.  Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp  N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA. Nat Med. 2015 Jan;21(1):71-5. doi: 10.1038/nm.3751. Epub 2014 Dec 8.  PubMed PMID: 25485910; PubMed Central PMCID: PMC4289115.
  8. Age-related clonal hematopoiesis associated with adverse outcomes. Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, Chavez A, Higgins JM, Moltchanov V, Kuo FC, Kluk MJ, Henderson B, Kinnunen L, Koistinen HA, Ladenvall C, Getz G, Correa A, Banahan BF, Gabriel S, Kathiresan S, Stringham HM, McCarthy MI, Boehnke M, Tuomilehto J, Haiman C, Groop L, Atzmon G, Wilson JG, Neuberg D, Altshuler D, Ebert BL.  N Engl J Med.  2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26. PubMed PMID: 25426837; PubMed Central PMCID: PMC4306669. 
  9. MDS is a stem cell disorder after all. Cancer Cell. Jaiswal S, Ebert BL. 2014  Jun 16;25(6):713-4. doi: 10.1016/j.ccr.2014.06.001. PubMed PMID: 24937455.

2003-2013

  1. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.  Han MH, Lundgren DH, Jaiswal S, Chao M, Graham KL, Garris CS, Axtell RC, Ho PP, Lock CB, Woodard JI, Brownell SE, Zoudilova M, Hunt JF, Baranzini SE, Butcher EC, Raine CS, Sobel RA, Han DK, Weissman I, Steinman L.  J Exp Med. 2012;209(7):1325-34. doi: 10.1084/jem.20101974. PubMed PMID: 22734047; PMCID: 3405500.
  2. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.  Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PO, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.  Proc Natl Acad Sci U S A. 2012;109(17):6662-7. doi: 10.1073/pnas.1121623109. PubMed PMID: 22451913; PMCID: 3340046.
  3. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.  Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, Weiskopf K, Willingham SB, Raveh T, Park CY, Majeti R, Weissman IL.  Sci Transl Med. 2010;2(63):63ra94. doi: 10.1126/scitranslmed.3001375. PubMed PMID: 21178137; PMCID: 4126904.
  4. Macrophages as mediators of tumor  immunosurveillance.  Jaiswal S, Chao MP, Majeti R, Weissman IL. Trends Immunol. 2010 Jun;31(6):212-9. doi: 10.1016/j.it.2010.04.001. Epub 2010 May 7. Review. PubMed PMID: 20452821; PubMed  Central PMCID: PMC3646798.
  5. Hematopoietic stem and progenitor cells and the inflammatory response.  Jaiswal S, Weissman IL.  Ann N Y Acad Sci. 2009;1174:118-21. doi: 10.1111/j.1749-6632.2009.04930.x. PubMed PMID: 19769744.
  6. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD, Jr., van Rooijen N, Weissman IL. Cell. 2009;138(2):286-99. doi: 10.1016/j.cell.2009.05.045. PubMed PMID: 19632179; PMCID: 2726837.
  7. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. Cell. 2009 Jul 23;138(2):271-85.  doi: 10.1016/j.cell.2009.05.046. PubMed PMID: 19632178; PubMed Central PMCID: PMC2775564.
  8.  Expression  of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Jaiswal S*, Traver D*, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10002-7. Epub 2003 Jul 30. PubMed PMID: 12890867; PubMed Central PMCID: PMC187741.

*Denotes equal contribution